AR096976A1 - COMPOSITIONS TO MODULATE TAU EXPRESSION - Google Patents
COMPOSITIONS TO MODULATE TAU EXPRESSIONInfo
- Publication number
- AR096976A1 AR096976A1 ARP140102674A ARP140102674A AR096976A1 AR 096976 A1 AR096976 A1 AR 096976A1 AR P140102674 A ARP140102674 A AR P140102674A AR P140102674 A ARP140102674 A AR P140102674A AR 096976 A1 AR096976 A1 AR 096976A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- tau expression
- modulate tau
- modulate
- expression
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000013498 tau Proteins Human genes 0.000 abstract 2
- 108010026424 tau Proteins Proteins 0.000 abstract 2
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos antisentido y métodos para disminuir la expresión de ARNm y proteínas Tau. Dichos métodos, compuestos y composiciones son de utilidad para tratar, prevenir o aliviar enfermedades, trastornos y condiciones asociadas a Tau.Antisense compounds and methods to decrease the expression of mRNA and Tau proteins. Said methods, compounds and compositions are useful for treating, preventing or alleviating diseases, disorders and conditions associated with Tau.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856551P | 2013-07-19 | 2013-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR096976A1 true AR096976A1 (en) | 2016-02-10 |
Family
ID=56125373
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102674A AR096976A1 (en) | 2013-07-19 | 2014-07-18 | COMPOSITIONS TO MODULATE TAU EXPRESSION |
| ARP210100989A AR121845A2 (en) | 2013-07-19 | 2021-04-14 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE EXPRESSION OF TAU |
| ARP210100993A AR121847A2 (en) | 2013-07-19 | 2021-04-14 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE EXPRESSION OF TAU |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100989A AR121845A2 (en) | 2013-07-19 | 2021-04-14 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE EXPRESSION OF TAU |
| ARP210100993A AR121847A2 (en) | 2013-07-19 | 2021-04-14 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE EXPRESSION OF TAU |
Country Status (1)
| Country | Link |
|---|---|
| AR (3) | AR096976A1 (en) |
-
2014
- 2014-07-18 AR ARP140102674A patent/AR096976A1/en active IP Right Grant
-
2021
- 2021-04-14 AR ARP210100989A patent/AR121845A2/en unknown
- 2021-04-14 AR ARP210100993A patent/AR121847A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR121845A2 (en) | 2022-07-13 |
| AR121847A2 (en) | 2022-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ755605A (en) | Compositions for modulating tau expression | |
| MX2016014140A (en) | Compositions and methods for modulating pkk expression. | |
| CY1124998T1 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF | |
| CL2019002535A1 (en) | Compositions to modulate the expression of sod-1. (Divisional application 201801897). | |
| UY37038A (en) | COMPOSITIONS AND METHODS TO DECREASE TAU EXPRESSION | |
| NI201600071A (en) | AUTOTAXIN INHIBITOR COMPOUNDS | |
| MX2016012123A (en) | Compositions for modulating ataxin 2 expression. | |
| MX2018006578A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions. | |
| EA201691872A1 (en) | HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS | |
| CL2016000326A1 (en) | Compositions and method to treat conditions associated with the complement | |
| MX2016002587A (en) | Modulation of prekallikrein (pkk) expression. | |
| TR201811764T4 (en) | Aminoheteroaryl benzamides as kinase inhibitors. | |
| UY35787A (en) | USEFUL COMPOSITIONS TO TREAT KIT-RELATED DISORDERS | |
| UA117470C2 (en) | Substituted xanthines and methods of use thereof | |
| EP3795148C0 (en) | USE OF FORMYLPEPTILE RECEPTOR 2 AGONISTS FOR THE TREATMENT OF OPHTHALMIC INFLAMMATION | |
| MX2015009058A (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases. | |
| EA201891347A1 (en) | Aza-benzimidazole inhibitors PAD4 | |
| IL246269B (en) | Compositions and methods for treating the accumulation of adipose tissue | |
| EA201690039A1 (en) | RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION | |
| NI201600070A (en) | AUTOTAXIN TETRAYCLIC INHIBITORS | |
| DK3049100T3 (en) | MODIFIED FIBROBLAST GROWTH FACTORS-1 FOR TREATMENT OF EYE DISORDERS | |
| WO2014140856A3 (en) | Mir-142 and antagonists thereof for treating disease | |
| AR096976A1 (en) | COMPOSITIONS TO MODULATE TAU EXPRESSION | |
| BR112016004054A2 (en) | compositions and methods for treating nasal conditions | |
| IT201700117749A1 (en) | Composition for treating constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |